Vimovo 50020 naproxen 500 MG esomeprazole magnesium trihydrate 22.3 MG Delayed Release Tablet

1 INDICATIONS AND USAGE VIMOVO is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. VIMOVO is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products. Controlled studies do not extend beyond 6 months. Relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID associated gastric ulcers (1)

AstraZeneca LP

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] diarrhoea` `[4] off label use` `[5] nausea` `[6] toxicity to various agents` `[7] death` `[8] completed suicide` `[9] pneumonia` `[10] pyrexia`

9 years ago

OVAL YELLOW 500 20

9 years ago

500 20 OVAL YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING VIMOVO 375 mg/20 mg tablets are oval, yellow film-coated tablets printed with 375/20 in black ink, supplied as: NDC 0186-0510-60 Bottles of 60 tablets VIMOVO 500 mg/20 mg tablets are oval, yellow film-coated tablets printed with 500/20 in black ink, supplied as: NDC 0186-0520-60 Bottles of 60 tablets NDC 0186-0520-39 Unit Dose Blisters, package of 100 tablets Storage: Store at 25°C (77°F); excursions permitted to 15- 30°C (59-86°F) [see USP Controlled Room Temperature]. Store in the original container and keep the bottle tightly closed to protect from moisture. Dispense in a tight container if package is subdivided.

More pills like OVAL 500 20

Related Pills

vimovo naproxen and esomeprazole magnesium tablet delayed release

horizon pharma inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site